Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Vafidemstat | 1357362-02-7 | 98.0% | 336.39 | 250 MG
Supplier: Medchemexpress LLC 250MGHY112623
Vafidemstat (ORY-2001) is an oral, brain penetrant, dual lysine-specific histone demethylase (LSD1)/MAO-B inhibitor. It is a novel epigenetic agent developed for the treatment of neurodegenerative diseases. It modulates LSD1, which participates in transcription regulation complexes, to adjust transcriptional imbalances in neurodegenerative diseases and to address neuroinflammation and cognitive deficits. Vafidemstat (ORY-2001) can also be used in the treatment of Alzheimer's disease.
- Oral, brain penetrant.
- Dual lysine-specific histone demethylase (LSD1)/MAO-B inhibitor.
- Novel epigenetic agent for the treatment of neurodegenerative diseases.
- Modulates LSD1 to tweak transcriptional imbalances in neurodegenerative disease.
- Redresses neuroinflammation and cognitive deficit.
- Can be used in the treatment of Alzheimer's disease.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?